MedAssets acquires SG-2 for approximately $142M MedAssets announced it signed a definitive agreement to acquire privately held SG-2 for approximately $142M to be funded with cash on hand and borrowings under its existing credit facility. Sg2 financial results and additional terms of the transaction were not disclosed. The transaction is subject to customary closing conditions and regulatory approvals, and is expected to be completed within 60 to 90 days.
MedAssets sees FY14 adjusted EPS near midpoint of $1.34-$1.38 range Sees FY14 adjusted EBITDA near low end of $234M-$238M range. Sees consolidated net revenue at midpoint of $715M-$721M range, consensus $716.44M. Says $28M in net revenue recognized in FY14 will not recur in FY15 due to conclusion of Barnabas RCM outsourcing agreement on December 31. Comments from slides that will be presented at the JP Morgan Healthcare Conference.
JPMorgan to hold a conference 33rd Annual Healthcare Conference is being held in San Francisco on January 12-15 with webcasted company presentations to begin on January 13 at 10:30 am; not all company presentations may be webcasted. Webcast Link